000 01088 a2200289 4500
005 20250517024818.0
264 0 _c20160328
008 201603s 0 0 ger d
022 _a1435-1250
024 7 _a10.1007/s00393-014-1563-0
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSchmalzing, M
245 0 0 _a[B cell therapy of rheumatoid arthritis with rituximab. Practice-relevant aspects for the routine].
_h[electronic resource]
260 _bZeitschrift fur Rheumatologie
_cApr 2015
300 _a250-7 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article; Review
650 0 4 _aAlgorithms
650 0 4 _aAntirheumatic Agents
_xadministration & dosage
650 0 4 _aArthritis, Rheumatoid
_xdiagnosis
650 0 4 _aB-Lymphocytes
_xdrug effects
650 0 4 _aHumans
650 0 4 _aRituximab
_xadministration & dosage
650 0 4 _aTreatment Outcome
700 1 _aTony, H-P
773 0 _tZeitschrift fur Rheumatologie
_gvol. 74
_gno. 3
_gp. 250-7
856 4 0 _uhttps://doi.org/10.1007/s00393-014-1563-0
_zAvailable from publisher's website
999 _c24785481
_d24785481